• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 5. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886

Introduction to 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine (CAS No. 59376-79-3)

5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine, also known by its CAS number 59376-79-3, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of amines and is characterized by its unique molecular structure, which includes a tetrahydro-naphthalene ring system substituted with two methyl groups at the 5 and 7 positions. The presence of these substituents imparts distinct chemical and biological properties to the molecule, making it a valuable candidate for various applications in drug discovery and development.

The molecular formula of 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine is C₁₂H₁₉N, with a molecular weight of approximately 177.28 g/mol. The compound's structure consists of a fused ring system with a central amine group, which can participate in various chemical reactions and interactions. This structural feature makes it an attractive scaffold for the synthesis of more complex molecules and derivatives.

In recent years, significant research efforts have been directed towards understanding the biological activities and potential therapeutic applications of 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine. Studies have shown that this compound exhibits a range of pharmacological properties, including anti-inflammatory, analgesic, and neuroprotective effects. These properties are attributed to its ability to modulate various signaling pathways and receptors in biological systems.

One notable area of research involves the use of 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine as a lead compound for the development of novel analgesics. Pain management remains a significant challenge in clinical practice, and there is a growing need for new therapeutic agents that can provide effective relief with minimal side effects. Research has demonstrated that this compound can effectively inhibit pain signaling pathways without causing significant toxicity or adverse reactions.

Beyond its analgesic properties, 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine has also shown promise in neuroprotective applications. Studies have indicated that it can protect neurons from oxidative stress and other forms of damage. This makes it a potential candidate for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The mechanism by which it exerts these protective effects is thought to involve its ability to scavenge free radicals and modulate intracellular signaling cascades.

In addition to its therapeutic potential, 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine has been explored as a tool in chemical biology research. Its unique structure allows it to serve as a scaffold for the design and synthesis of probes that can be used to study protein-protein interactions and other cellular processes. This application has broad implications for understanding fundamental biological mechanisms and developing new diagnostic tools.

The synthesis of 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine has been optimized through various synthetic routes. One common approach involves the reduction of the corresponding nitrile or amide followed by subsequent functional group manipulations. These synthetic methods have been refined to achieve high yields and purity levels, making the compound readily available for both academic and industrial research.

The safety profile of 5,7-Dimethyl-1,2,3,4-tetrahydro-naphthalen-1-ylamine has been extensively evaluated in preclinical studies. Toxicity assessments have shown that it exhibits low toxicity at therapeutic concentrations. However, as with any chemical compound used in biomedical applications, appropriate safety precautions should be taken during handling and use.

In conclusion, 5，7-Dimethyl-1，2，3，4-tetrahydro-naphthalen-1-yamine (CAS No. 59376-79-3) is a multifaceted compound with significant potential in various areas of medicinal chemistry and pharmaceutical research. Its unique structural features and diverse biological activities make it an attractive candidate for further exploration and development. Ongoing research continues to uncover new applications and insights into its mechanisms of action, highlighting its importance in advancing our understanding of complex biological systems.

• 61341-86-4((1S)-indan-1-amine)
• 2217-40-5(1,2,3,4-Tetrahydro-1-naphthylamine)
• 34698-41-4(indan-1-amine)
• 10277-74-4((1R)-2,3-dihydro-1H-inden-1-amine)
• 473732-55-7(1-(2-Methylphenyl)propylamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)